Company Filing History:
Years Active: 2022-2024
Title: Si Tuen Lee-Hoeflich: Innovator in Antibody Drug Conjugates
Introduction
Si Tuen Lee-Hoeflich is a prominent inventor based in Lexington, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibody drug conjugates. With a total of 2 patents, her work focuses on innovative solutions for medical treatments.
Latest Patents
Her latest patents include groundbreaking inventions related to antibody drug conjugates for ablating hematopoietic stem cells. The present invention provides antibody drug conjugates, wherein an antibody or antibody fragment that specifically binds to human cKIT is linked to a drug moiety, optionally through a linker. Furthermore, the invention includes pharmaceutical compositions comprising the antibody drug conjugates and methods of making and using such pharmaceutical compositions for ablating hematopoietic stem cells in patients in need thereof.
Career Highlights
Si Tuen Lee-Hoeflich is currently associated with Novartis AG, a leading global healthcare company. Her role at Novartis allows her to leverage her expertise in biotechnology and contribute to the advancement of medical therapies.
Collaborations
Throughout her career, she has collaborated with notable colleagues, including Anthony E Boitano and Matthew T Burger. These collaborations have further enhanced her research and development efforts in the field.
Conclusion
Si Tuen Lee-Hoeflich is a remarkable inventor whose work in antibody drug conjugates is paving the way for innovative medical treatments. Her contributions to biotechnology are significant and continue to impact the healthcare industry positively.